Driehaus Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Driehaus Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-841,677	Closed	-$19.9M	–	462
2023 Q4	$19.9M	Buy	+841,677	New	+$15M	0.24%	139

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Driehaus Capital Management's CBAY Position: Q1 2024 in Review

Driehaus Capital Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 841,677 shares — an estimated $19.9M sold.

Driehaus Capital Management first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $19.9M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Driehaus Capital Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Driehaus Capital Management sold 841,677 Cymabay Therapeutics shares in Q1 2024, an estimated $19.9M.
Driehaus Capital Management first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Driehaus Capital Management's Cymabay Therapeutics position peaked at $19.9M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Driehaus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.